Michigan Cancer Research Consortium Community Clinical Oncology Program is a clinical research site located in Ann Arbor, Michigan, United States 48106.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Michigan Cancer Research Consortium Community Clinical Oncology Program has participated in 24 clinical trials with 2 currently active.
Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Michigan Cancer Research Consortium Community Clinical Oncology Program has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Michigan Cancer Research Consortium Community Clinical Oncology Program has 24 clinical trials on record, with 2 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Yes — Michigan Cancer Research Consortium Community Clinical Oncology Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.